Matches in Wikidata for { <http://www.wikidata.org/entity/Q90124367> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q90124367 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q90124367 description "scientific article published on 01 July 2019" @default.
- Q90124367 description "wetenschappelijk artikel" @default.
- Q90124367 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q90124367 name "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 name "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 type Item @default.
- Q90124367 label "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 label "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 prefLabel "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 prefLabel "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 P1433 Q90124367-F9D95AF4-F9AF-4FB6-8D15-798AB92E30FD @default.
- Q90124367 P1476 Q90124367-451EA3BB-A6C8-4148-ADCD-83A1D47FE3DD @default.
- Q90124367 P2093 Q90124367-00875823-AEF8-4194-9645-5D08DA336159 @default.
- Q90124367 P2093 Q90124367-215FED31-3FA3-4BCE-B2BF-9D797DA07F18 @default.
- Q90124367 P2093 Q90124367-2CC420D6-9A6B-4A0A-9D9C-71B408145EF7 @default.
- Q90124367 P2093 Q90124367-43A0F863-1847-4ABD-83D2-AA0589C1ECC3 @default.
- Q90124367 P2093 Q90124367-4503A25E-F5F6-4DAC-98D0-03CA9FD3A1BF @default.
- Q90124367 P2093 Q90124367-5B4F7D0C-C306-41D9-91D5-5EB4A48F5F53 @default.
- Q90124367 P2093 Q90124367-660983D2-5AB4-4903-93DB-26837B77B804 @default.
- Q90124367 P2093 Q90124367-D801D9EB-DF4F-4A4E-83A5-283100BDFC95 @default.
- Q90124367 P2093 Q90124367-EB8D4F8F-8C37-436B-9D30-8476F78D6EFA @default.
- Q90124367 P304 Q90124367-7E72B1A8-C75C-4822-95B1-D4205A93D932 @default.
- Q90124367 P31 Q90124367-E62D51CC-EF85-4233-AA32-29B0E6BED35C @default.
- Q90124367 P356 Q90124367-209D064A-D923-4182-A4D1-84205AE0948B @default.
- Q90124367 P433 Q90124367-3E2EF617-E685-42F6-8F0B-50CB718A1B7F @default.
- Q90124367 P478 Q90124367-692A6186-0025-49A6-8F6C-F5EB2A031A7F @default.
- Q90124367 P577 Q90124367-171A8237-47A8-442C-8646-98C62FFE3ECD @default.
- Q90124367 P698 Q90124367-59FA9DAE-2E0F-4541-968C-330E0584F3C8 @default.
- Q90124367 P921 Q90124367-710781FF-DB71-4E3C-BA6C-A5225CD52680 @default.
- Q90124367 P356 HYZ049 @default.
- Q90124367 P698 31008509 @default.
- Q90124367 P1433 Q2231629 @default.
- Q90124367 P1476 "Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings" @default.
- Q90124367 P2093 "Akihiko Gemma" @default.
- Q90124367 P2093 "Akinobu Yoshimura" @default.
- Q90124367 P2093 "Emiko Ohki" @default.
- Q90124367 P2093 "Katsuko Sugaya" @default.
- Q90124367 P2093 "Motoko Tamura" @default.
- Q90124367 P2093 "Naomi Ueno" @default.
- Q90124367 P2093 "Satoshi Hashigaki" @default.
- Q90124367 P2093 "Shigeo Banno" @default.
- Q90124367 P2093 "Yutaka Endo" @default.
- Q90124367 P304 "676-686" @default.
- Q90124367 P31 Q13442814 @default.
- Q90124367 P356 "10.1093/JJCO/HYZ049" @default.
- Q90124367 P433 "7" @default.
- Q90124367 P478 "49" @default.
- Q90124367 P577 "2019-07-01T00:00:00Z" @default.
- Q90124367 P698 "31008509" @default.
- Q90124367 P921 Q3658562 @default.